Biopharma

Abstract Lipid nanoparticle (LNP) formulations have enabled the in vivo delivery of messenger ribonucleic acid (mRNA) vaccines and therapeutics yet...

Abstract Reverse micelles (RM) have played a central role in biotechnology, yet their pharmaceutical use has been constrained by instability,...

The large-scale global application of messenger ribonucleic acid–lipid nanoparticles (mRNA-LNPs) is severely restricted by their mandatory ultra-low-temperature storage requirement, which...

Abstract The aim of this study was to assess to what extent a simulated trehalose monolayer can predict the minimum...

August, 2026 Commercialization follows strong interest from pharmaceutical developers worldwide Ashland Inc. (NYSE: ASH), has announced the launch of permexa™...

Abstract Pediatric maintenance therapy for acute lymphoblastic leukemia requires prolonged daily administration of 6-mercaptopurine (6-MP), a drug characterized by a...

Abstract Polymers offer a promising alternative to established lipid nanoparticles for therapeutic RNA delivery. Here, we introduce alkyl-chain-quaternized poly(vinylpyrrolidone-co-4-vinylpyridine) copolymers...

Viatel™ polymers are used in the fabrication of degradable medical devices and tissue engineering solutions. medical devices and tissue engineering...

Lille, France, September 30, 2026 Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and leading technical...

Abstract The most relevant challenge concerning the semi-solid extrusion 3D printing (SSE) pharmaceutical application is the development of versatile inks...